• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定表观遗传调节剂作为核大小和形状的决定因素。

Identification of epigenetic modulators as determinants of nuclear size and shape.

机构信息

National Cancer Institute, Bethesda, United States.

Department of Molecular Biology, University of Wyoming, Laramie, United States.

出版信息

Elife. 2023 May 23;12:e80653. doi: 10.7554/eLife.80653.

DOI:10.7554/eLife.80653
PMID:37219077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10259489/
Abstract

The shape and size of the human cell nucleus is highly variable among cell types and tissues. Changes in nuclear morphology are associated with disease, including cancer, as well as with premature and normal aging. Despite the very fundamental nature of nuclear morphology, the cellular factors that determine nuclear shape and size are not well understood. To identify regulators of nuclear architecture in a systematic and unbiased fashion, we performed a high-throughput imaging-based siRNA screen targeting 867 nuclear proteins including chromatin-associated proteins, epigenetic regulators, and nuclear envelope components. Using multiple morphometric parameters, and eliminating cell cycle effectors, we identified a set of novel determinants of nuclear size and shape. Interestingly, most identified factors altered nuclear morphology without affecting the levels of lamin proteins, which are known prominent regulators of nuclear shape. In contrast, a major group of nuclear shape regulators were modifiers of repressive heterochromatin. Biochemical and molecular analysis uncovered a direct physical interaction of histone H3 with lamin A mediated via combinatorial histone modifications. Furthermore, disease-causing lamin A mutations that result in disruption of nuclear shape inhibited lamin A-histone H3 interactions. Oncogenic histone H3.3 mutants defective for H3K27 methylation resulted in nuclear morphology abnormalities. Altogether, our results represent a systematic exploration of cellular factors involved in determining nuclear morphology and they identify the interaction of lamin A with histone H3 as an important contributor to nuclear morphology in human cells.

摘要

细胞核的形状和大小在不同的细胞类型和组织中具有高度的可变性。核形态的变化与疾病有关,包括癌症,以及过早和正常衰老。尽管核形态具有非常基本的性质,但决定核形状和大小的细胞因素还不是很清楚。为了以系统和无偏的方式鉴定核结构的调节剂,我们针对包括染色质相关蛋白、表观遗传调节剂和核膜成分在内的 867 种核蛋白进行了高通量成像 siRNA 筛选。使用多个形态计量参数,并排除细胞周期效应物,我们确定了一组新的核大小和形状决定因素。有趣的是,大多数鉴定出的因子改变了核形态,而不影响核纤层蛋白的水平,核纤层蛋白是已知的核形状的主要调节因子。相比之下,一组主要的核形状调节剂是抑制性异染色质的修饰因子。生化和分子分析揭示了组蛋白 H3 通过组合组蛋白修饰与核纤层 A 之间的直接物理相互作用。此外,导致核形状破坏的致病核纤层 A 突变抑制了核纤层 A-组蛋白 H3 相互作用。致癌组蛋白 H3.3 突变体缺乏 H3K27 甲基化导致核形态异常。总之,我们的研究结果代表了对决定核形态的细胞因子的系统探索,它们确定了核纤层 A 与组蛋白 H3 的相互作用是人类细胞核形态的一个重要贡献因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/0e5c035b4c87/elife-80653-fig6-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/46d59f9a15f0/elife-80653-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/3915e1ba9c69/elife-80653-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/5b0fd08e5252/elife-80653-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/da3c135ecebe/elife-80653-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/92ac58e07d07/elife-80653-fig1-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/f2c323053287/elife-80653-fig1-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/676f7e5d71b1/elife-80653-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/cf47795359ee/elife-80653-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/73c182df703a/elife-80653-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/b374fe2e5da9/elife-80653-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/8f790bead2d0/elife-80653-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/72a465395bcc/elife-80653-fig3-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/183d46302f23/elife-80653-fig3-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/01a41a0b58dd/elife-80653-fig3-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/4f79e3f0d9db/elife-80653-fig3-figsupp6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/61a74f66ee57/elife-80653-fig3-figsupp7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/14673318b6ed/elife-80653-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/9d613802dc6a/elife-80653-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/2f82be086a3f/elife-80653-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/f4de674c748d/elife-80653-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/530892ce9482/elife-80653-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/3f30c8b320b3/elife-80653-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/1d9cf1addcb9/elife-80653-fig6-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/baf51650037b/elife-80653-fig6-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/0e5c035b4c87/elife-80653-fig6-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/46d59f9a15f0/elife-80653-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/3915e1ba9c69/elife-80653-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/5b0fd08e5252/elife-80653-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/da3c135ecebe/elife-80653-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/92ac58e07d07/elife-80653-fig1-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/f2c323053287/elife-80653-fig1-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/676f7e5d71b1/elife-80653-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/cf47795359ee/elife-80653-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/73c182df703a/elife-80653-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/b374fe2e5da9/elife-80653-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/8f790bead2d0/elife-80653-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/72a465395bcc/elife-80653-fig3-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/183d46302f23/elife-80653-fig3-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/01a41a0b58dd/elife-80653-fig3-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/4f79e3f0d9db/elife-80653-fig3-figsupp6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/61a74f66ee57/elife-80653-fig3-figsupp7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/14673318b6ed/elife-80653-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/9d613802dc6a/elife-80653-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/2f82be086a3f/elife-80653-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/f4de674c748d/elife-80653-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/530892ce9482/elife-80653-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/3f30c8b320b3/elife-80653-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/1d9cf1addcb9/elife-80653-fig6-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/baf51650037b/elife-80653-fig6-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f8/10259489/0e5c035b4c87/elife-80653-fig6-figsupp5.jpg

相似文献

1
Identification of epigenetic modulators as determinants of nuclear size and shape.鉴定表观遗传调节剂作为核大小和形状的决定因素。
Elife. 2023 May 23;12:e80653. doi: 10.7554/eLife.80653.
2
Lamin A rod domain mutants target heterochromatin protein 1alpha and beta for proteasomal degradation by activation of F-box protein, FBXW10.核纤层蛋白 A 杆状结构域突变体通过激活 F-box 蛋白 FBXW10,将异染色质蛋白 1α 和β靶向到蛋白酶体降解。
PLoS One. 2010 May 13;5(5):e10620. doi: 10.1371/journal.pone.0010620.
3
The NSL complex maintains nuclear architecture stability via lamin A/C acetylation.核小体稳定复合物通过核纤层蛋白 A/C 的乙酰化作用维持核架构稳定性。
Nat Cell Biol. 2019 Oct;21(10):1248-1260. doi: 10.1038/s41556-019-0397-z. Epub 2019 Oct 1.
4
Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging.突变型核纤层蛋白A会导致早衰过程中表观遗传控制的渐进性改变。
Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8703-8. doi: 10.1073/pnas.0602569103. Epub 2006 May 31.
5
Nuclear envelope localization of LEMD2 is developmentally dynamic and lamin A/C dependent yet insufficient for heterochromatin tethering.LEMD2的核膜定位在发育过程中具有动态变化,依赖于核纤层蛋白A/C,但对于异染色质的锚定来说并不充分。
Differentiation. 2017 Mar-Apr;94:58-70. doi: 10.1016/j.diff.2016.12.002. Epub 2017 Jan 2.
6
Chromatin histone modifications and rigidity affect nuclear morphology independent of lamins.染色质组蛋白修饰和刚性独立于核纤层影响核形态。
Mol Biol Cell. 2018 Jan 15;29(2):220-233. doi: 10.1091/mbc.E17-06-0410. Epub 2017 Nov 15.
7
Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathy.下颌-肢端发育不良(一种罕见的核纤层蛋白病)中核膜和染色质组织的改变
Physiol Genomics. 2005 Oct 17;23(2):150-8. doi: 10.1152/physiolgenomics.00060.2005. Epub 2005 Jul 26.
8
Knock-down of methyl CpG-binding protein 2 (MeCP2) causes alterations in cell proliferation and nuclear lamins expression in mammalian cells.甲基化CpG结合蛋白2(MeCP2)的敲低会导致哺乳动物细胞中细胞增殖和核纤层蛋白表达的改变。
BMC Cell Biol. 2012 Jul 11;13:19. doi: 10.1186/1471-2121-13-19.
9
The human granulocyte nucleus: Unusual nuclear envelope and heterochromatin composition.人类粒细胞细胞核:异常的核膜和异染色质组成。
Eur J Cell Biol. 2008 May;87(5):279-90. doi: 10.1016/j.ejcb.2008.02.007. Epub 2008 Apr 8.
10
Monitoring of Chromatin Organization at the Nuclear Pore Complex, Inner Nuclear Membrane, and Nuclear Interior in Live Cells by Fluorescence Ratiometric Imaging of Chromatin (FRIC).通过染色质荧光比率成像(FRIC)对活细胞中核孔复合体、内核膜和核内部的染色质组织进行监测。
Methods Mol Biol. 2022;2502:151-160. doi: 10.1007/978-1-0716-2337-4_10.

引用本文的文献

1
Cellular senescence in cancer: from mechanism paradoxes to precision therapeutics.癌症中的细胞衰老:从机制悖论到精准治疗
Mol Cancer. 2025 Aug 8;24(1):213. doi: 10.1186/s12943-025-02419-2.
2
Epigenome and three-dimensional genome architecture remodeling during NDM29-mediated retro-transformation of neuroblastoma cells.神经母细胞瘤细胞在NDM29介导的逆转转化过程中的表观基因组和三维基因组结构重塑
PLoS One. 2025 Jul 31;20(7):e0327466. doi: 10.1371/journal.pone.0327466. eCollection 2025.
3
Constitutive heterochromatin controls nuclear mechanics, morphology, and integrity through H3K9me3 mediated chromocenter compaction.

本文引用的文献

1
The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest.2023 年的 STRING 数据库:针对任何感兴趣的测序基因组的蛋白质-蛋白质关联网络和功能富集分析。
Nucleic Acids Res. 2023 Jan 6;51(D1):D638-D646. doi: 10.1093/nar/gkac1000.
2
Loss of lamin-B1 and defective nuclear morphology are hallmarks of astrocyte senescence in vitro and in the aging human hippocampus.核层蛋白 B1 的缺失和核形态缺陷是体外星形胶质细胞衰老和衰老人类海马体的标志。
Aging Cell. 2022 Jan;21(1):e13521. doi: 10.1111/acel.13521. Epub 2021 Dec 10.
3
Epigenetic regulation of nuclear lamina-associated heterochromatin by HAT1 and the acetylation of newly synthesized histones.
组成型异染色质通过H3K9me3介导的染色中心压缩来控制核力学、形态和完整性。
Nucleus. 2025 Dec;16(1):2486816. doi: 10.1080/19491034.2025.2486816. Epub 2025 Apr 9.
4
The nuclear periphery confers repression on H3K9me2-marked genes and transposons to shape cell fate.核周区域对H3K9me2标记的基因和转座子施加抑制作用,以塑造细胞命运。
Nat Cell Biol. 2025 Jul 22. doi: 10.1038/s41556-025-01703-z.
5
How the chromatin landscape influences nuclear morphology.染色质景观如何影响细胞核形态。
Front Cell Dev Biol. 2025 Jul 3;13:1634252. doi: 10.3389/fcell.2025.1634252. eCollection 2025.
6
Peripheral chromatin remodeling at the center of zygotic genome activation.合子基因组激活核心处的外周染色质重塑
Cell Genom. 2025 Jul 9;5(7):100922. doi: 10.1016/j.xgen.2025.100922.
7
Orderly mitosis shapes interphase genome architecture.有序的有丝分裂塑造了间期基因组结构。
bioRxiv. 2025 Jun 3:2025.06.03.657645. doi: 10.1101/2025.06.03.657645.
8
Perturb-tracing enables high-content screening of multi-scale 3D genome regulators.扰动追踪能够对多尺度3D基因组调控因子进行高内涵筛选。
Nat Methods. 2025 May;22(5):950-961. doi: 10.1038/s41592-025-02652-z. Epub 2025 Apr 10.
9
Chromosome mis-segregation triggers cell cycle arrest through a mechanosensitive nuclear envelope checkpoint.染色体错分离通过机械敏感的核膜检查点触发细胞周期停滞。
Nat Cell Biol. 2025 Jan;27(1):73-86. doi: 10.1038/s41556-024-01565-x. Epub 2025 Jan 8.
10
Nuclear Structure, Size Regulation, and Role in Cell Migration.核结构、大小调控及其在细胞迁移中的作用。
Cells. 2024 Dec 23;13(24):2130. doi: 10.3390/cells13242130.
组蛋白乙酰转移酶 HAT1 对核纤层相关异染色质的表观遗传调控及新合成组蛋白的乙酰化作用。
Nucleic Acids Res. 2021 Dec 2;49(21):12136-12151. doi: 10.1093/nar/gkab1044.
4
Nuclear size and shape control.核大小和形状控制。
Semin Cell Dev Biol. 2022 Oct;130:90-97. doi: 10.1016/j.semcdb.2021.10.013. Epub 2021 Nov 12.
5
Molecular Pathology of Laminopathies.层粘连蛋白病的分子病理学。
Annu Rev Pathol. 2022 Jan 24;17:159-180. doi: 10.1146/annurev-pathol-042220-034240. Epub 2021 Oct 21.
6
Regulation of diverse nuclear shapes: pathways working independently, together.多种细胞核形态的调控:相互独立、协同作用的途径
Commun Integr Biol. 2021 Jul 5;14(1):158-175. doi: 10.1080/19420889.2021.1939942. eCollection 2021.
7
The shifting shape of genomes: dynamics of heterochromatin interactions at the nuclear lamina.基因组的不断变化:核纤层中异染色质相互作用的动态变化。
Curr Opin Genet Dev. 2021 Apr;67:163-173. doi: 10.1016/j.gde.2021.02.003. Epub 2021 Mar 25.
8
Functional mechanisms and abnormalities of the nuclear lamina.核层的功能机制和异常。
Nat Cell Biol. 2021 Feb;23(2):116-126. doi: 10.1038/s41556-020-00630-5. Epub 2021 Feb 8.
9
Deterioration of nuclear morphology and architecture: A hallmark of senescence and aging.核形态和结构的恶化:衰老和老化的标志。
Ageing Res Rev. 2021 May;67:101264. doi: 10.1016/j.arr.2021.101264. Epub 2021 Feb 2.
10
Histone H3.3 beyond cancer: Germline mutations in cause a previously unidentified neurodegenerative disorder in 46 patients.组蛋白 H3.3 并不仅限于癌症:46 名患者的种系突变导致一种先前未识别的神经退行性疾病。
Sci Adv. 2020 Dec 2;6(49). doi: 10.1126/sciadv.abc9207. Print 2020 Dec.